Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 130,000,000
Countries
Sector(s)
Poland : € 130,000,000
Services : € 130,000,000
Signature date(s)
18/12/2018 : € 130,000,000
Link to source

Summary sheet

Release date
30 May 2018
Status
Reference
Signed | 18/12/2018
20170342
Project name
Promoter - financial intermediary
ADVANCED MEDICAL RESEARCH POLAND II
REPUBLIC OF POLAND
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 130 million
EUR 325 million
Location
Sector(s)
  • Services - Professional, scientific and technical activities
Description
Objectives

The project will support the medical research carried out in the public medical universities and medical scientific institutes in Poland from 2018 to 2020.

The purpose of the project is to enhance the quality and efficiency of scientific work and to augment academic research activities undertaken at medical universities and medical research institutes. The project is fully consistent with the Bank's Knowledge Economy objectives and Horizon 2020 targets. About 70% of the investments will take place in the convergence regions.

Environmental aspects
Procurement

The project concerns investments in universities and public research facilities, which are not specifically mentioned in the Directive 2014/52/EU on Environmental Impact Assessment, though the project may be covered by Annex II of the Directive in relation to urban development. Full environmental details will be assessed during the appraisal, including the potential impacts of some of the capital investments concerned.

The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directives 2004/18/EC and/or 2004/17/EC as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.

Link to source
Other links

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - ADVANCED MEDICAL RESEARCH POLAND II
Publication Date
14 Sep 2018
Document language
Main Topic
Lending
Document Number
83814481
Document Focus
Environmental Information
Project Number
20170342
Sector(s)
Regions
Countries
Publicly available
Download now
Environmental and Social Completion Sheet (ESCS) - ADVANCED MEDICAL RESEARCH POLAND II
Publication Date
25 Dec 2021
Document language
Main Topic
Lending
Document Number
140543288
Document Focus
Environmental Information
Project Number
20170342
Sector(s)
Regions
Countries
Publicly available
Download now

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications